calendar
30,570 catalysts · 11,006 approval · 5,000 device 510k · 4,728 grant · 3,045 8k filing · 2,000 device pma · 2,000 device recall
30,570 catalysts · 11,006 approval · 5,000 device 510k · 4,728 grant · 3,045 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: PH HEALTH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL
Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION
Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: LUNDBECK PHARMS LLC. Form: FOR SOLUTION. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SOLUTION. Route: ORAL
Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL
Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL
Sponsor: ORGANON USA LLC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL
Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL
Sponsor: TEVA. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVEN PHARMS INC. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: SANDOZ. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: SANDOZ. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SANDOZ. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: TABLET, DELAYED RELEASE. Route: ORAL